Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other neoplasm 1Other hematologic neoplasm 1Myeloid 1CNS 1

Conditions

Precancerous Conditions 12Neoplasms 4Stomach Neoplasms 3Rare Malignant Neoplasm 3Esophageal Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Skin Diseases 2Pancreatic Neoplasms 2Obesity-Related Malignant Neoplasm 2Neoplasms by Site 2Neoplasms by Histologic Type 2Keratosis, Actinic 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Venentoclax 1Uterine Prolapse 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Tongue Neoplasms 1Syndrome 1Stomach Ulcer 1Small Cell Lung Carcinoma 1Secondary Malignant Neoplasm of Liver 1Salivary Gland Neoplasms 1Salivary Gland Malignant Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pathologic Processes × Other neoplasm × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡